olmesartan/amlodipino/hct stadapharma efg 40/5/12,5 mg 28 comprimits rec
olmesartan/amlodipino/hct stadapharma efg 40/5/25 mg 28 comprimits rec
norfloxa stadapharm 400 mg
solifenacin/tamsulosin stadapharm 6 mg/0,4 mg tabletten mit veränderter wirkstofffreisetzung
mesna-cell 100 mgml
mbi pharma ltd., israel - mesna - solution for injection - mesna 100 mg / 1 ml - mesna - prevention of urinary tract toxicity of oxazaphosphorines (ifosfamide, cyclophosphamide or trofosfamide) in particular patients at risk. risks are in particular previous radiation therapy in the area of the true pelvis, cystitis following previous therapy with ifosfamide, cyclophosphamide or trofosfamide and a history of uropathy.
rivastigmin tiefenbacher 3 mg hartkapseln
rivastigmin stada 1,5 mg hartkapseln
rivastigmin tiefenbacher 6 mg hartkapseln
rivastigmin stada 3 mg hartkapseln
rivastigmin stada 4,5 mg hartkapseln